Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...

Imagine waking up already feeling drained, as if you never slept at all. Or noticing that your hands feel inexplicably stiff and swollen, making simple tasks like opening a jar or even typing feel ...

People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around. Researchers have ...

For the first time, an off-the-shelf CAR T cell therapy has been used to treat potentially life-threatening autoimmune disorders in three people. With a single shot, the treatment rapidly reversed ...

Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. What are called autoimmune diseases can ...

Add Yahoo as a preferred source to see more of our stories on Google. Still, that means about 10% of people with lupus and 30% with rheumatoid arthritis are men, notes Louis Bridges, Jr., MD, PhD, ...

Sunshine Cruz underscored the importance of consistency, crediting it for her continuous fitness progress amid being ...

TMA’s innovative, nutrition-focused research proposal is one of 15 projects selected in crowd-sourced search for ideas ...

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

Candidate has potential to be a first-in-class treatment offering biologic-like disease control from an oral small moleculeRegulatory submission ...

HitIndiaFitIndia: Beware! Persistent pain and muscle weakness could be one of the first sign that your body may send when you ...

Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be initiated in the first quarter of 2025 Company plans to report initial clinical data from Phase ...